Valeant Pharmaceuticals, the Canadian company that took over Bausch & Lomb a year ago for $8.7 billion, has proposed to take over Allergan as well, at a price that would reportedly value the company at $45.6 billion. It's a very high price for Allergan, which made a net profit of ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.